Results 261 to 270 of about 138,032 (344)

Recognition of Transfusion With Microcytic Packed Red Blood Cells on ADVIA 2120i RBC V/HC Cytograms: A Case Report

Veterinary Clinical Pathology, EarlyView.
ABSTRACT A 3‐year‐old, intact female Havanese dog was presented for treatment of a relapse of suspected immune‐mediated anemia and thrombocytopenia. Over the course of treatment, the patient's anemia appeared to acutely transition from macrocytic and hypochromic to microcytic and hypochromic between days five and six of hospitalization.
Hannah R. Cohen, Matthew K. Wun, Jillian Haines, Sarah C. Guess, Mara S. Varvil, K. Jane Wardrop   +5 more
wiley   +1 more source

Influence of Anxiety Level and Degree of Alexithymia on Quality of Life in Adult Patients With Primary Immune Thrombocytopenia. [PDF]

Actas Esp Psiquiatr
Liang S, Wu T, Chai L, Ai T, Lu S.
europepmc   +1 more source

Spotlight on eltrombopag in the treatment of children with chronic immune thrombocytopenia

, 2016
Michele P. Lambert
openalex   +2 more sources

ESM‐1 and GBP‐1 are associated with endothelial dysfunction: emerging biomarkers or key players in the pathophysiology of preeclampsia?

The Journal of Physiology, EarlyView.
Abstract figure legend Endothelial specific molecule‐1 (ESM‐1) and guanylate binding protein‐1 (GBP‐1) are proteins that are produced by activated/dysfunctional endothelial cells and are increased and decreased, respectively, during preeclampsia. It remains to be established whether ESM‐1 and GBP‐1 could potentially be included as biomarkers for the ...
Ines Pronk, Joost H. N. Schuitemaker, Marijke M. Faas, Alexandra M. Smink   +3 more
wiley   +1 more source

Original Versus Generic Eltrombopag in Patients with Immune Thrombocytopenia: A Prospective Multi-Center Experience on Efficacy and Safety. [PDF]

J Clin Med
Çelik S, Karabulut ZT, Selim C, Çiftçiler R, Yıldız A, Yaman S, Pınar İE, Eroğlu Küçükdiler AH, Açar NG, Şentürk Yıkılmaz A, Demircan V, Keskin D, Açar İH, Kırcalı E, Kurt Yüksel M.   +14 more
europepmc   +1 more source

Additional file 1 of Multimethodological and multiscale investigation of the therapeutic mechanism of Qian Ji Sheng Xue Pian in treating primary immune thrombocytopenia

Yujue Wang, Chengyan Liu, Xiaoqi Sun, Weijie Zhang, Hailin Chen, Wenwei Zhu   +5 more
openalex   +1 more source

Aging‐Derived Alterations in Genomic, Immune, and Metabolic Networks: Implications for Cancer Development and Therapy

MedComm – Oncology, Volume 5, Issue 1, March 2026.
Ageing acts as a double‐edged sword in cancer. In the elderly, open chromatin, immunosenescence, and chronic inflammation drive SASP (IL‐6, MMPs), MDSC accumulation and T‐cell suppression, fostering tumor‐promoting microenvironments and limited therapeutic benefit.
Qi Wang, Xue Sun, Xinhao Han, Xingda Zhang, Wenzheng Wang, Hongbin Wang, He Ren, Lina Gu   +7 more
wiley   +1 more source

Rilzabrutinib for the Treatment of Immune Thrombocytopenia. [PDF]

Eur J Haematol
Labanca C, Martino EA, Vigna E, Bruzzese A, Mendicino F, Caridà G, Lucia E, Olivito V, Manicardi V, Amodio N, Neri A, Morabito F, Gentile M.   +12 more
europepmc   +1 more source

Pediatric Cerebral Sinovenous Thrombosis Associated With Thrombopoietin Receptor Agonist in the Treatment of Chronic Immune Thrombocytopenia [PDF]

Maurisa Rapp, Marie Martinelli
openalex   +1 more source

Sex Differences in Response to Viral Vector Vaccines—Implications for Future Vaccine Design

Immunological Reviews, Volume 338, Issue 1, March 2026.
ABSTRACT Vaccination represents one of the most impactful public health achievements, preventing 3.5 to 5 million deaths annually according to estimates of the World Health Organization. Yet, recent outbreaks of emerging and reemerging infectious diseases highlight the need for rapid and strategic vaccine development using vaccine platforms ...
Ilka Grewe, Tamara Zoran, Marylyn Martina Addo   +2 more
wiley   +1 more source